CSM Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1863523 WARRENDALE, PA

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$55,794,161

+$1,336,596 QoQ

Shares Held

219,688

-1.4% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

1.33%

of 13F equity value

Holder Rank

#417

of 4,664 holders

Holding Since

Jun 2021

16 quarters on record

Voting authority Sole 69% Shared 0% None 31%

Healthcare · as of Jun 30, 2026

CSM Advisors, LLC holds $167,508,675 across 11 Drug Manufacturers - General names. JNJ ranks #1 (33.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	219,688	$55,794,161
2	ABBV	AbbVie Inc.	143,403	$36,085,930
3	LLY	ELI LILLY & Co	27,478	$32,957,940
4	PFE	Pfizer Inc	889,436	$21,417,618
5	SNY	Sanofi	360,443	$15,376,498
6	NVS	Novartis AG	11,160	$1,748,995
7	MRK	Merck & Co., Inc.	10,162	$1,305,817
8	GILD	Gilead Sciences, Inc.	9,282	$1,172,687

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$55,794,161	219,688	-1.4%	Shares	Sole	2026-08-14
2026-03-31	$54,457,565	222,785	-13.0%	Shares	Sole	2026-05-15
2025-12-31	$52,987,478	256,040	+3.8%	Shares	Sole	2026-02-11
2025-09-30	$45,744,411	246,707	+94.5%	Shares	Sole	2025-11-14
2025-06-30	$19,372,518	126,825	+9678.3%	Shares	Sole	2025-08-07
2023-12-31	$203,291	1,297	0.0%	Shares	Sole	2024-02-14
2023-09-30	$202,007	1,297	-13.4%	Shares	Sole	2023-11-13
2023-06-30	$247,783	1,497	-28.6%	Shares	Sole	2023-08-14
2023-03-31	$325,035	2,097	0.0%	Shares	Sole	2023-05-15
2022-12-31	$370,435	2,097	0.0%	Shares	Sole	2023-02-14
2022-09-30	$342,565	2,097	0.0%	Shares	Sole	2022-11-14
2022-06-30	$372,238	2,097	0.0%	Shares	Sole	2022-08-11
2022-03-31	$371,651	2,097	0.0%	Shares	Sole	2022-05-16
2021-12-31	$358,733	2,097	-32.3%	Shares	Sole	2022-02-09
2021-09-30	$500,165	3,097	0.0%	Shares	Sole	2021-11-15
2021-06-30	$510,199	3,097	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.